Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- VIVUS Announces Change to Presentation Time at the Barclays Capital Small & Mid-Cap Healthcare Forum
Nov 05, 2008 08:03 AM
- VIVUS Reports Third Quarter 2008 Financial Results
Nov 04, 2008 04:03 PM
- VIVUS Announces Upcoming Webcasts and Conference Participation
Nov 03, 2008 08:09 AM
- VIVUS Announces Date of Third Quarter 2008 Financial Results and Conference Call
Oct 31, 2008 09:37 AM
- VIVUS Announces the Weight Loss Effects of Qnexa in Type 2 Diabetes
Oct 06, 2008 12:46 PM
- VIVUS to Present at the 2008 UBS Life Sciences Conference
Sep 17, 2008 04:31 PM
- VIVUS to Present at the Merriman Curhan Ford Investor Summit 2008
Sep 09, 2008 08:10 AM
- VIVUS to Present at the BioCentury NewsMakers Conference
Aug 28, 2008 04:03 PM
- VIVUS to Present at the Noble Financial Equity Conference
Aug 13, 2008 04:02 PM
- VIVUS Announces Closing of $65 Million Registered Direct Offering of Common Stock
Aug 06, 2008 11:16 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
VVUS
|
Compare to S&P
|
| YTD |
4.44 %
|
89.24 %
|
| 4 Weeks |
-11.17 %
|
-1.25 %
|
| 12 Weeks |
-35.90 %
|
-5.13 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -100.00 %
|
|
EPS Growth in Last Year: -100.00 %
|
|
Sales Growth in Last Quarter: 0.82 %
|
|
Sales Growth in Last Quarter: 33.47 %
|
|
|
